Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. - Test2 - elhamkhani - TriplyDB

Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.

Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.

http://www.wikidata.org/entity/Q36493469

about

Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis Immune cell promotion of metastasis Immune regulation of bone metastasis Targeting tumor-stromal interactions in bone metastasis Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression Role of plasmacytoid dendritic cell subsets in allergic asthma The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy.Location of tumor affects local and distant immune cell type and number Contributions of the host microenvironment to cancer-induced bone disease.Deciphering and reversing tumor immune suppression.Signaling between tumor cells and the host bone marrow microenvironment.Neuropilin 1: function and therapeutic potential in cancer.Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.Designing effective vaccines for colorectal cancer.Immunosuppressive cells in tumor immune escape and metastasis.HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease.Role of plasmacytoid dendritic cells in breast cancer bone dissemination.Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy Prognostic impact of high levels of circulating plasmacytoid dendritic cells in breast cancer.Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer.Treg: tolerance vs immunity.Disease-Associated Plasmacytoid Dendritic Cells.18β-Glycyrrhetinic acid from licorice root impairs dendritic cells maturation and Th1 immune responses.The Biology of Bone Metastasis.Gastric cancer patients have elevated plasmacytoid and CD1c+ dendritic cells in the peripheral blood.Organotropism: new insights into molecular mechanisms of breast cancer metastasis.

P2860

Q26749368-0E1C7D9A-6DD8-46D2-A180-0DA3856C0FF0 Q26991724-73FAC6C3-D9C6-4E5D-BC13-0DC9E3B0B6F5 Q27005871-54B60433-3A69-402E-9A36-01DF4EFFF8F9 Q27024561-4C047021-B19A-4504-B956-08704F37D843 Q27325140-00B961E3-D685-43E4-B150-8FC3A8156BB2 Q29542292-5EF1D3D6-AD55-4FBF-AFD9-0D7815554153 Q30317628-26F7BA8A-A596-4B9F-A4BF-850ACFBAA8F4 Q34655006-EEE47389-BDC0-4382-8A9B-61EFFB21443E Q35549911-773D16A8-A087-47DB-85CA-7B3326E5919C Q35583409-06FCF185-2824-4B95-9672-F0B73FD8C72B Q35763478-488D864D-121E-4902-97F8-FD4EA5FAC6C5 Q37067495-32D68C2D-3FF9-480D-8F9A-B2F846191618 Q37619977-B432FCF7-57B0-4CBC-927C-2DB97276F7DA Q37660747-BC6215A2-07AE-4451-A378-2ED23A5E96D8 Q37663962-61A654DB-1BB8-4D87-BFAD-F0A8A974922E Q38124437-4D2B882C-DB10-4501-95AE-D29C11ED19E4 Q38138849-F255B795-873E-45D9-B048-CD2F7E1A2CFB Q38165001-6A83BF6E-7A3B-42FB-B3CA-8D36A08BD45A Q38177689-67FEE45E-0391-421F-988B-0765C43E2DD1 Q38260051-FCB76C62-4652-48C0-BB6F-3053F1B2C694 Q38675140-0C905859-646C-4F86-95CC-DA88D6FF69CA Q38930365-40D21CB9-8005-4DB1-85BF-9EE81CCD45FF Q39028177-5381AD1B-63CA-4EDC-AB15-1F443F200FA5 Q41219325-D5989890-C679-4BB9-AFC3-02C7E02F2594 Q42064906-50222B0E-5853-4E88-854D-1C7762F4B3C2 Q42654195-5F221366-B1AF-427E-9222-843B98ACEBC5 Q42753871-13DBE729-AFC6-4A00-B790-5FCAC7F71235 Q43015717-84CB130D-ABF3-4F3F-80B2-F0BD6A16D1CE Q43164219-D264A685-74B9-4F88-926B-06B374452E1A Q43930865-F8874F05-55F5-49BE-BD3A-F231B9A7F9C9 Q45358227-8AAB51A0-C08D-4073-9DF7-E9FD3FA112FE Q50175870-1C599D38-80F3-4AC6-B810-C141693ACB25 Q55345501-2384EE64-A01B-498C-B978-40BAA6251F74 Q55353906-0D34A2E3-83EC-42F5-BA29-45EF11D9090F

P2860

Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells.

http://www.wikidata.org/entity/Q36493469

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@ast

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@en

type

label

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@ast

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@en

prefLabel

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@ast

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@en

P1433

Q36493469-ABC20978-0E5C-4E6D-8B05-8D8C07781A9B

P1476

Q36493469-626D3DA6-0396-4B95-B42B-424FAFB6C416

P2093

Q36493469-181591F7-2B48-4AEB-8115-88EA00C0F58D

Q36493469-27D99B5F-C359-4FFC-822A-92DEFE8BF4B2

Q36493469-4464A43F-D328-446C-A446-574B6995F4FE

Q36493469-68D600EA-20CA-4E74-AA6C-77747396405E

Q36493469-8E7DD681-232A-4A8E-973D-09E17CB917F5

Q36493469-CCD196BA-38C0-4B5F-9E1F-34D0197CE806

P2860

Q36493469-001AB1D7-8318-4480-803E-C2A6C86E9D93

Q36493469-05CE12F3-6108-4AFE-A724-6DDF6ADFDC94

Q36493469-1031C5A2-2A70-47CE-902B-94DA87689512

Q36493469-12EC4503-7A52-4A34-A6BF-C33615C33341

Q36493469-1716E249-56B2-45A7-B8F2-E701BF598F49

Q36493469-1950ACD3-0663-4E75-AFE6-CD416A8966C1

Q36493469-2249C8E8-1EF1-48FE-BD2D-27E69AFDC859

Q36493469-39701CD9-C40D-4660-9145-61293E5948A9

Q36493469-3BB08F0E-A533-4DEB-93D2-179BD0325734

Q36493469-3DAFBAF1-7F4C-4F49-A0CC-C989245E1FA5

P304

Q36493469-2B183CE1-C061-4EC9-ADE3-4D3409CC973D

P31

Q36493469-D4C99A52-4EB0-4D57-8F82-81E5DF5269E2

P356

Q36493469-86D7902E-A0B3-4F40-B5A7-3A910CED91CD

P407

Q36493469-27209216-B3F6-4F99-B6A3-309ADFDB2EFA

P433

Q36493469-773971CA-2319-4D76-A0EE-ECADE6B0DDD5

P478

Q36493469-49989E48-3214-4081-BD30-6F6CAD3D94E5

P50

Q36493469-7AC7B978-1343-44EE-B3E6-B0630F1175AB

P577

Q36493469-AC9A643F-C2BE-4C0B-9B01-2104B5E9E54A

P698

Q36493469-97C8E749-4F0E-4C7F-BCED-A9B58FC3385D

P932

Q36493469-E66F5083-9618-4BE9-9CD7-1B22309C0398

P356

JIMMUNOL.1101855

P1433

Journal of Immunology

P1476

Depletion of plasmacytoid dend ...... stasis of breast cancer cells.

@en

P2093

Akhil Maheshwari

http://www.w3.org/2001/XMLSchema#string

Anandi Sawant

http://www.w3.org/2001/XMLSchema#string

Brittney A Harris

http://www.w3.org/2001/XMLSchema#string

Diptiman Chanda

http://www.w3.org/2001/XMLSchema#string

Jonathan A Hensel

http://www.w3.org/2001/XMLSchema#string

Selvarangan Ponnazhagan

http://www.w3.org/2001/XMLSchema#string

P2860

Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo

IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking

Metastasis to bone: causes, consequences and therapeutic opportunities

Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis.

Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.

Mechanisms of bone metastasis.

Molecular control of bone remodeling and osteoporosis.

Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

P304

4258-4265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1101855

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

189

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23018462

http://www.w3.org/2001/XMLSchema#string

P932

3531993

http://www.w3.org/2001/XMLSchema#string